These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 2878979

  • 1. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J, Sebens JB.
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [Abstract] [Full Text] [Related]

  • 2. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
    Korf J, Sebens JB, Flentge F, van der Werf JF.
    J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
    [Abstract] [Full Text] [Related]

  • 3. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF, Van het Schip F, Sebens JB, Korf J.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):387-99. PubMed ID: 6436037
    [Abstract] [Full Text] [Related]

  • 4. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
    MacKenzie RG, Zigmond MJ.
    J Neurochem; 1984 Nov 20; 43(5):1310-8. PubMed ID: 6208330
    [Abstract] [Full Text] [Related]

  • 5. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM, Benfenati F, Farabegoli C, Fuxe K, Meller E, Aronsson M, Goldstein M, Agnati LF.
    Brain Res; 1987 Dec 01; 435(1-2):147-52. PubMed ID: 2962698
    [Abstract] [Full Text] [Related]

  • 6. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M, Dubois A, Benavidès J, Scatton B.
    Neurosci Lett; 1988 Feb 15; 85(1):119-24. PubMed ID: 2834672
    [Abstract] [Full Text] [Related]

  • 7. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 8. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 22; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 9. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R, Scavone C, Camillo MA.
    Braz J Med Biol Res; 1989 Jan 22; 22(6):741-3. PubMed ID: 2620186
    [Abstract] [Full Text] [Related]

  • 10. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES, Csernansky JG, Hollister LE.
    Life Sci; 1988 Jan 22; 43(8):715-20. PubMed ID: 2901023
    [Abstract] [Full Text] [Related]

  • 11. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF, Thal L, Gardner EL.
    Psychopharmacology (Berl); 1982 Jan 22; 76(2):182-7. PubMed ID: 6805029
    [Abstract] [Full Text] [Related]

  • 12. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S, Coward D.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb 22; 335(2):115-22. PubMed ID: 2951601
    [Abstract] [Full Text] [Related]

  • 13. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P, Kerwin R, Rupniak NM, Murugaiah K, Hall MD, Fleminger S, Marsden CD.
    J Neural Transm Suppl; 1983 Feb 22; 18():205-12. PubMed ID: 6135741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 18. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR, Johnson KM.
    J Pharmacol Exp Ther; 1989 Feb 28; 248(2):521-30. PubMed ID: 2918468
    [Abstract] [Full Text] [Related]

  • 19. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E, Bohmaker K, Goldstein M, Schweitzer JW, Friedhoff AJ.
    Eur J Pharmacol; 1985 Mar 12; 109(3):389-94. PubMed ID: 3157587
    [Abstract] [Full Text] [Related]

  • 20. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.
    Neve KA, Marshall JF.
    Neurosci Lett; 1984 Apr 20; 46(1):77-83. PubMed ID: 6203067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.